Literature DB >> 6322905

Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.

B F Murphy, J A Whitworth, P Kincaid-Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6322905      PMCID： PMC1441650          DOI： 10.1136/bmj.288.6420.844

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Captopril/diuretic combinations in severe renovascular disease: a cautionary note.

Authors:  M L Watson; G M Bell; A L Muir; T A Buist; R J Kellett; P L Padfield
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

2.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney.

Authors:  D E Hricik; P J Browning; R Kopelman; W E Goorno; N E Madias; V J Dzau
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

3.  Repeated renal failure with use of captopril in a cystinotic renal allograft recipient.

Authors:  D Hooke; R G Walker; N M Walter; A J D'Apice; J A Whitworth; P Kincaid-Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

4.  Intrarenal role of angiotensin II and [des-Asp1]angiotensin II.

Authors:  J E Hall; T G Coleman; A C Guyton; J W Balfe; H C Salgado
Journal:  Am J Physiol       Date:  1979-03
  4 in total
  10 in total

Review 1.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 2.  Safety profiles of the angiotensin-converting enzyme inhibitors.

Authors:  N J Warner; J E Rush
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Congestive heart failure and converting enzyme inhibition: failure of current prognostic criteria for predicting subsequent renal insufficiency.

Authors:  J Odum; P Carson; G Russell
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

Review 4.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 5.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

6.  Reversible renal failure after combined treatment with enalapril and frusemide in a patient with congestive heart failure.

Authors:  C Funck-Brentano; G Chatellier; J M Alexandre
Journal:  Br Heart J       Date:  1986-06

Review 7.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

8.  Lisinopril pharmacokinetics in chronic renal failure.

Authors:  B Jackson; R B Cubela; E L Conway; C I Johnston
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

Review 9.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 10.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.